CapsoVision CV
NASDAQ CV
$6.02 +0.11 (+1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

CapsoVision (CV) Cash from Financing Activities (2024 - 2025)

CapsoVision (CV) posted Cash from Financing Activities of $15000.0 for Q4 2025, down 99.93% sequentially from $22.4 million in Q3 2025, and down 99.7% YoY from $5.0 million in Q4 2024.

CapsoVision (CV) Cash from Financing Activities (2024 - 2025) Analysis & Trends

CapsoVision has reported Cash from Financing Activities for 2 years, with the latest figure at $15000.0 in Q4 2025.

  • Quarterly Cash from Financing Activities fell 99.7% year-over-year to $15000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.4 million (changed N/A YoY) and the FY2025 annual result came in at $23.6 million, up 56.59% from the prior year.
  • Cash from Financing Activities slipped to $15000.0 in Q4 2025 per CV's latest filing, from $22.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $22.4 million in Q3 2025 and troughed at $15000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 CapsoVision 299.87 Mn 290.80 Mn 1.87 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 15,000.00
Dec 31, 2025 15,000.00
Sep 30, 2025 22.39 Mn
Sep 30, 2025 22.39 Mn
Dec 31, 2024 5.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 10.00 Mn
Sep 30, 2024 10.00 Mn